DJ Incyte Corp. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Incyte Corp. $(INCY)$ slid 2.82% to $119.52 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.70% to 7,489.72 and the Dow Jones Industrial Average rising 0.53% to 52,485.03.
This was the stock's third consecutive day of losses.
Incyte Corp. closed 9.86% short of its 52-week high of $132.60, which the company reached on July 28th.
The stock underperformed when compared to some of its competitors Friday, as Alnylam Pharmaceuticals Inc. $(ALNY)$ rose 0.02% to $205.52, Bio-Techne Corp. (TECH) rose 0.08% to $72.09, and BioMarin Pharmaceutical Inc. $(BMRN)$ fell 0.92% to $60.02.
Trading volume (1.8 M) remained 132,425 below its 50-day average volume of 2.0 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 31, 2026.